For automated capture of end points, aims were to (1) develop and test methods to collect end point–defining image files for patients participating in clinical trials, (2) develop a data model and ...
Real-World Data (RWD) has become one of the most widely discussed topics across the global medtech sector. But what is driving this increased attention? In reality, collecting data from clinicians and ...
The US Food and Drug Administration (FDA) is working on ways to facilitate greater use of real-world data (RWD) to help understand the safety and efficacy of medications used during pregnancy and ...
Clayton Irvine, PharmD, MBA, MS, explains that leveraging high-quality, real-world data; cross-institutional collaboration; standardized care pathways; advanced technologies; and integrated ...
Selecting appropriate machine learning (ML) methods for domain-specific tasks remains a persistent challenge, particularly in medicine where datasets are often small, heterogeneous, and incomplete.
On December 15, 2025, the US Food and Drug Administration (FDA) issued a press release announcing that FDA eliminated a major barrier to the use of real-world evidence (RWE) in medical device ...
The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...
CAR T-cell therapies are individualized treatments approved for multiple hematologic malignancies, with improved management of adverse effects over time. Access to CAR T-cell therapies is limited by ...
In the late 1800s, the U.S. railroad system didn’t just revolutionize transportation—it catalyzed entirely new industries. Refrigerated railcars enabled a national meatpacking economy. Standard time ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results